After facing difficulties in 2016, healthcare investor Jacob Gottlieb has bounced back with a new firm that is going to change the healthcare investment industry. He has created Altium Capital Management LP, with offices in New York. With less than two years in operation, this firm is doing exceptionally well. The growth report released showing the numbers from 2017 indicated a company that has a great start. One of the main Altium Capital’s products is the Altium Growth Fund, LP which recorded a 7.37 percent return. What makes performance impressive is that it was recorded within five months. Altium Capital Management, LP was opened mid-2017.
What does Altium Capital do?
Altium Capital is an investment company that looks for opportunities in the healthcare industry. It invests in companies in this industry that show great potential for growth. Jacob Gottlieb is a titan in the healthcare industry due to his success as a healthcare entrepreneur. He works with firms that offer meaningful and innovative treatment solutions. The main areas that Altium Capital Fund focuses on include equity-linked products, small-cap equities and mid-cap equities. The fund invests in the US and international healthcare sub-sectors. Some of the areas they consider include medical technology and medical devices, biotech, specialty and major pharma, services, among others.
The New Healthcare Investment Approach
Investment is a rigorous activity that mainly involves taking advantage of pricing differences in mid and small-caps sectors. Altium strategy involves investing in businesses that have solutions that address global healthcare concerns. Each investment made by Altium is based on a bottom-up analysis, whereby the value of an investment is based on the risk-reward ratio.
Altium Capital Management has brought together a group of experts who have experience dealing with high-stake investments. These are professionals who are well-versed with financial knowledge as well as healthcare expertise. Most of the professionals working for the company are experienced employees with various hedge funds. The company is now at an advantage of having highly- qualified experts who can help the company in the process of going up. The main model of investment used by this firm is fundamental analysis.
Jacob Gottlieb is the founder, the managing partner and the chief executive officer of this firm. He has recruited experienced professionals with successful careers to assist him in managing it. The team leading this company is dedicated to long-term development, and therefore there are keen on optimizing their work such that it addresses the needs of the future.
Altium Capital has already made some significant investments. Some of these investments include Oramed Pharmaceuticals, Amarin Corporation and Oragenics, all in the healthcare sector. Oramed is one of the companies that are coming up with a highly innovative way of handling medical treatment. It is coming up with an alternative oral treatment to the injectable drugs used for the treatment of diabetes. Amarin on its part is creating drugs to boost cardiovascular health.
Jacob holds the senior most position in this firm. He is assisted by Mark Gottlieb who is the chief operating officer. Before Altium Capital was created, he was the chief technology officer at Visium Asset Management. LLC. He helped this firm rise from 2005 to 2016, when it had over $8 billion in assets. He had previously worked with Balyasny Asset Management, L.P, where he set the record as the top earner through his portfolio profits. His career started at Merlin Financial in London, where he became a successful investment portfolio manager. Gottlieb holds a degree in economics from Brown University and MD from New York University Medical School.